Related Experiment Video
Updated: Jul 1, 2025

07:46
Author Spotlight: Achieving High-Purity In Vitro Differentiation of Th17 Cells Using Cytokine Concentration Modulation
Published on: October 25, 2024
3.0K
IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials
Choong-Hyun Koh1, Byung-Seok Kim2, Chang-Yuil Kang3
1Laboratory of Immune Regulation, Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 08826, Korea.
Immune Network
|March 8, 2024
Summary
Interleukin-17 (IL-17) and Interleukin-21 (IL-21) are vital immune-modulating cytokines. Understanding their roles in immunity, inflammation, and disease is key to developing new therapies.
Area of Science:
- Immunology
- Molecular Biology
- Cellular Biology
Background:
- Interleukin-17 (IL-17) and Interleukin-21 (IL-21) are critical cytokines influencing immune responses.
- IL-17 is essential for defense against pathogens and maintaining microbiota balance, but its dysregulation causes inflammation and autoimmunity.
- IL-21 links innate and adaptive immunity, with imbalances contributing to autoimmune diseases and cancer.
Purpose of the Study:
- To provide an updated review of the immunobiology of IL-17 and IL-21.
- To explore the therapeutic potential of targeting IL-17 and IL-21 for various diseases.
- To enhance understanding of the complex roles these cytokines play in health and disease.
Main Methods:
- This review synthesizes current research and literature on IL-17 and IL-21.
- Analysis of published studies over the last two decades.
- Discussion of immunoregulatory functions and disease associations.
Main Results:
- IL-17 and IL-21 are central to diverse immune system functions.
- Dysregulation of these cytokines is linked to significant pathological conditions, including autoimmune disorders and cancer.
- Their dual role in host defense and disease pathogenesis is highlighted.
Conclusions:
- A comprehensive understanding of IL-17 and IL-21 immunobiology is crucial.
- Targeting IL-17 and IL-21 offers promising therapeutic avenues for immune-mediated diseases and cancer.
- Further research into these cytokines will advance immunological insights and treatment strategies.
Related Concept Videos
T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
Cytotoxic T Cells-mediated Immune Response
908
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
908

